44 results on '"Cloete, Ruben"'
Search Results
2. Neurexin 2 p.G849D variant, implicated in Parkinson’s disease, increases reactive oxygen species, and reduces cell viability and mitochondrial membrane potential in SH-SY5Y cells
3. The determination of the effect(s) of solute carrier family 22-member 2 (SLC22A2) haplotype variants on drug binding via molecular dynamic simulation systems
4. Structure based identification of novel inhibitors against ATP synthase of Mycobacterium tuberculosis: A combined in silico and in vitro study
5. Interaction analysis of statistically enriched mutations identified in Cameroon recombinant subtype CRF02_AG that can influence the development of Dolutegravir drug resistance mutations
6. Structural and functional effects of nucleotide variation on the human TB drug metabolizing enzyme arylamine N-acetyltransferase 1
7. State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach
8. Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson’s disease pathobiology
9. The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity
10. The Flexible, Extended Alpha Helix Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity
11. Molecular Modeling of Subtype-Specific Tat Protein Signatures to Predict Tat-TAR Interactions That May Be Involved in HIV-Associated Neurocognitive Disorders
12. Author response for 'Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders'
13. In silico repurposing of a Novobiocin derivative for activity against latency associated Mycobacterium tuberculosis drug target nicotinate-nucleotide adenylyl transferase (Rv2421c)
14. Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
15. Figure S1;Table S1;Table S2 from Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
16. Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
17. Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care
18. Prioritization of candidate genes for a South African family with Parkinson’s disease using in-silico tools
19. Comparative studies of the seven human coronavirus envelope proteins using topology prediction and molecular modelling to understand their pathogenicity
20. Short Communication: HIV-1 Drug Resistance Mutation Analyses of Cameroon-Derived Integrase Sequences
21. Structural Comparison of Diverse HIV-1 Subtypes using Molecular Modelling and Docking Analyses of Integrase Inhibitors
22. Repurposing Novobiocin for activity against latency associated Mycobacterium tuberculosis drug target nicotinate-nucleotide adenylyltransferase (Rv2421c)
23. Interaction Analysis of Statistically Enriched Mutations Identified in Cameroon Recombinant Subtype CRF02_AG that can Influence the Development of Dolutegravir Drug Resistance Mutations
24. Genome Sequencing of a Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Obtained from a South African Patient with Coronavirus Disease 2019
25. Correction: Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding
26. Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding
27. HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms Among Integrase Strand Transfer Inhibitor-Naive HIV-1 Patients from Cameroon
28. Whole-Genome Sequence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) obtained from a South African Coronavirus Disease 2019 (COVID-19) Patient on behalf of the SA-COVID-19 response team
29. Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
30. Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding
31. Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c
32. Author Correction: Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and availability of integrase inhibitors in Cape Town, South Africa
33. Designing a course model for distance-based online bioinformatics training in Africa: The H3ABioNet experience
34. Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and availability of integrase inhibitors in Cape Town, South Africa
35. Additional file 10: Figure S5. of Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis
36. Additional file 1: Table S1. of Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis
37. Additional file 5: Figure S1. of Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis
38. Additional file 6: Figure S2. of Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis
39. Additional file 7: Figure S3. of Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis
40. Additional file 9: Figure S4. of Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis
41. Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis
42. Comparative Analysis of Mycobacterium tuberculosis pe and ppe Genes Reveals High Sequence Variation and an Apparent Absence of Selective Constraints
43. HIV-1 diversity and the implementation of integrase strand-transfer inhibitors as part of combination antiretroviral therapy.
44. Designing a course model for distance-based online bioinformatics training in Africa: The H3ABioNet experience.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.